Civitas Therapeutics
A privately-held biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically-proven ARCUS dry powder pulmonary delivery platform
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Aug 2014 | $55M | $220M | Wellington Management · Fountain Healthcare Partners · Canaan · Longitude Capital | — |
| SERIES BOther financing | Sep 2013 | $38M | $152M | Fountain Healthcare Partners · Canaan · Alkermes · Longitude Capital | — |
Growth signals
Latest recorded traffic for Civitas Therapeutics is 60 monthly website visits. Civitas Therapeutics's team declined 3.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Civitas Therapeutics in the Chelsea ecosystem
The Civitas Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Canaan
Longitude Capital- BCBay City Capital
Fountain Healthcare Partners
Alkermes
RA Capital Management
Series B and later5 investors entered at this stage
Wellington Management
Sofinnova Investments
Rock Springs Capital
OrbiMed
PFM Health Sciences
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Civitas Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Civitas Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










